Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to give kidney patients real choices beyond dialysis

NCT ID NCT06243068

Knowledge-focused Sponsor: George Washington University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests two ways to help older adults with kidney failure make informed choices about their care. One approach offers education and decision aids; the other adds a supportive care program for those who choose non-dialysis options. Researchers will compare how many patients choose alternative treatments and how they feel about their care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 3,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2024

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Study Population 1: Person with CKD, cared for at participating clinic Inclusion Criteria: * Age 65 years or older * Most recent eGFR \<30 at time of screening AND meets practice site criteria for KDE referral * Treatment naïve (no dialysis or kidney transplant prior to enrollment) Exclusion Criteria: * The current decrease in eGFR is thought to be due to an acute event. * Education and initiation of shared decision-making process are not yet indicated for the patient, (per practice protocol and/or provider's judgment). Exclusion Criteria for surveys and interviews: * Insufficient decision-making capacity * Non-English and non-Spanish speaking * Treating nephrologist/APP opts patient out (for example, if contraindicated for patient's health) Study Population 2: Family member or care partner of patient in Study Population 1 Inclusion Criteria: * Family member or care partner of Population 1 patient who has chosen active medical care without dialysis and consented to decisional conflict surveys * 18+ years old * English or Spanish speaking * Cognitively able to participate in surveys/interviews Study Population 3: Administrator, clinical provider, or staff at participating chronic kidney disease clinic Inclusion Criteria: \- Currently practicing or employed at participating clinic

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic kidney disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic kidney disease

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    25 sites. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Clinical Renal Associates

    Exton, Pennsylvania, 19341, United States

  • Medstar Washington Hospital Center

    Washington D.C., District of Columbia, 20010, United States

  • North Texas Kidney Disease Associates

    Lewisville, Texas, 75057, United States

  • North Texas Kidney Disease Associates

    North Richland Hills, Texas, 76180, United States

  • North Texas Kidney Disease Associates

    Plano, Texas, 75093, United States

  • Penn Presbyterian Medical Center

    Philadelphia, Pennsylvania, 19104, United States

  • Perelman Center for Advanced Medicine

    Philadelphia, Pennsylvania, 19104, United States

  • Renal Disease Research Institute

    Dallas, Texas, 75246, United States

  • Renal Disease Research Institute

    Fort Worth, Texas, 76104, United States

  • Renal Disease Research Institute

    Garland, Texas, 75044, United States

  • Renal Disease Research Institute

    Irving, Texas, 75061, United States

  • Renal Disease Research Institute

    McKinney, Texas, 75069, United States

  • Renal Disease Research Institute

    McKinney, Texas, 75071, United States

  • Renal Disease Research Institute

    Mesquite, Texas, 75150, United States

  • Renal Disease Research Institute

    Plano, Texas, 75093, United States

  • Southeast Kidney Associates

    Canton, Georgia, 30114, United States

  • Southeast Kidney Associates

    East Point, Georgia, 30344, United States

  • St. Clair Nephrology

    Shelby, Michigan, 48315, United States

  • The Rogosin Institute Manhattan Eat Dialysis

    New York, New York, 10021, United States

  • UCSF/Zuckerberg San Francisco General Hospital and Trauma Center-Nephrology

    San Francisco, California, 94110, United States

  • Virginia Nephrology Group

    Alexandria, Virginia, 22304, United States

  • Virginia Nephrology Group

    Arlington, Virginia, 22205, United States

  • Virginia Nephrology Group

    Fairfax, Virginia, 22030, United States

  • West Virginia University Medicine

    Fairmont, West Virginia, 26554, United States

  • West Virginia University Medicine

    Morgantown, West Virginia, 26506, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.